PentaLyte (R) does not decrease heparinoid release but does decrease circulating thrombotic mediator activity associated with aortic occlusion-reperfusion in rabbits

Citation
Vg. Nielsen et al., PentaLyte (R) does not decrease heparinoid release but does decrease circulating thrombotic mediator activity associated with aortic occlusion-reperfusion in rabbits, ANESTH ANAL, 92(2), 2001, pp. 314-319
Citations number
19
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
ANESTHESIA AND ANALGESIA
ISSN journal
00032999 → ACNP
Volume
92
Issue
2
Year of publication
2001
Pages
314 - 319
Database
ISI
SICI code
0003-2999(200102)92:2<314:P(DNDH>2.0.ZU;2-7
Abstract
Hemorrhage and thrombosis are associated with major vascular and trauma sur gery. Release of heparinoids and thrombotic mediators may contribute to the se complications and have been described in rabbits after aor tic occlusion -reperfusion. We hypothesized that the resuscitative fluid used could reduc e heparinoid and thrombotic mediator release after aortic occlusion-reperfu sion in rabbits as assessed by thromboelastographic variables (R, reaction time; alpha, angle; and G, a measure of clot strength). Anesthetized rabbit s were administered lactated Ringer's solution (n = 8) or Pentalyte(R) (n = 8) at reperfusion after 30 min of ischemia. Blood was obtained before isch emia and after 30 min of reperfusion for thromboelastography under four con ditions: 1) unmodified sample, 2) platelet inhibition, 3) heparinase, and 4 ) platelet inhibition and heparinase. During reperfusion, unmodified sample s demonstrated a significant increase in A and decrease in or and G that wa s not affected by PentaLyte(R). In the presence of heparinase, no significa nt fluid-specific thromboelastographic differences were noted. However, thr ombotic mediator release (discerned by a decrease in R and an increase in o r) during reperfusion in samples with platelet inhibition and heparinase wa s significantly attenuated by PentaLyte(R). PentaLyte(R) administration doe s not decrease heparinoid release but does decrease thrombotic mediator rel ease after aortic occlusion-reperfusion.